On Friday October 25, 2024 Regencell Bioscience Reported FY24 EPS $(0.33) Up From $(0.45) YoY
Portfolio Pulse from Benzinga Newsdesk
Regencell Bioscience reported a quarterly loss of $(0.33) per share, an improvement from the $(0.45) per share loss in the same period last year, marking a 26.67% increase.
October 28, 2024 | 3:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Regencell Bioscience reported a quarterly EPS loss of $(0.33), an improvement from $(0.45) last year, indicating a 26.67% increase in EPS.
The improvement in EPS from $(0.45) to $(0.33) suggests better financial performance, which is likely to positively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100